接受抗抑郁治疗的血液透析患者及其肾脏科医生的接受度
本研究基于2009至2011年一项血液透析患者症状管理临床试验,每月用患者健康问卷9评估抑郁。101例患者中39例符合抑郁标准,在147次月度评估中70%已用抗抑郁药,但70%的强化治疗建议和91%的起始治疗建议未被患者接受;患者拒绝主因是将抑郁归因于急性事件、慢性病或透析。18次患者接受建议中11次肾脏科医生不愿提供治疗。
要点
- 透析抑郁患者常不愿调整或启动抗抑郁治疗,多归因于急性事件、慢性病或透析。
- 患者接受建议时,肾脏科医生也常不愿提供抗抑郁治疗。
- 改善透析患者抑郁管理需解决患者和医生层面的障碍。
核心结论
- 慢性血液透析抑郁患者常对调整或启动抗抑郁治疗不感兴趣,常将抑郁归因于近期急性事件、慢性病或透析。
- 肾脏科医生常不愿调整或启动抗抑郁治疗。
- 未来改善抑郁管理需解决这些患者和医生层面的障碍。
研究设计与样本
- 研究为2009至2011年一项慢性血液透析患者症状管理临床试验的一部分。
- 每月用患者健康问卷9评估抑郁,抑郁定义为评分≥10分。
- 由受训护士生成治疗建议并在患者和医生接受时帮助实施治疗。
- 评估患者对建议的接受度、拒绝原因及医生实施抗抑郁治疗的意愿。
- 数据分析单位为月度评估。
主要发现
- 101例患者随访≤12个月,39例在一次或多次评估中符合抑郁标准(患者健康问卷9评分≥10分)。
- 39例抑郁患者在373次月度评估中的147次(39%)存在抑郁。
- 147次抑郁评估中103次(70%)患者正在接受抗抑郁治疗。
- 70次强化治疗建议中51次(70%)患者不接受护士建议。
- 44次抑郁评估中患者未接受抗抑郁治疗,其中40次(91%)不接受起始治疗建议。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Depression is common in patients receiving chronic hemodialysis but seems to be ineffectively treated. We investigated the acceptance of antidepressant treatment by patients on chronic hemodialysis and their renal providers. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: As part of a clinical trial of symptom management in patients on chronic hemodialysis conducted from 2009 to 2011, we assessed depression monthly using the Patient Health Questionnaire 9. For depressed patients (Patient Health Questionnaire 9 score ≥10), trained nurses generated treatment recommendations and helped implement therapy if patients and providers accepted the recommendations. We assessed patients' acceptance of recommendations, reasons for refusal, and provider willingness to implement antidepressant therapy. We analyzed data at the level of the monthly assessment. RESULTS: Of 101 patients followed for ≤12 months, 39 met criteria for depression (Patient Health Questionnaire 9 score ≥10 on one or more assessments). These 39 patients had depression on 147 of 373 (39%) monthly assessments. At 103 of these 147 (70%) assessments, patients were receiving antidepressant therapy, and at 51 of 70 (70%) assessments, patients did not accept nurses' recommendations to intensify treatment. At 44 assessments, patients with depression were not receiving antidepressant therapy, and in 40 (91%) instances, they did not accept recommendations to start treatment. The primary reason that patients refused the recommendations was attribution of their depression to an acute event, chronic illness, or dialysis (57%). In 11 of 18 (61%) instances in which patients accepted the recommendation, renal providers were unwilling to provide treatment. CONCLUSIONS: Patients on chronic hemodialysis with depression are frequently not interested in modifying or initiating antidepressant treatment, commonly attributing their depression to a recent acute event, chronic illness, or dialysis. Renal providers are often unwilling to modify or initiate antidepressant therapy. Future efforts to improve depression management will need to address these patient- and provider-level obstacles to providing such care.
引用
- Pena-Polanco JE, Mor MK, Tohme FA, et al. Acceptance of Antidepressant Treatment by Patients on Hemodialysis and Their Renal Providers. Clin J Am Soc Nephrol. 2017. PMID: 28126707. doi:10.2215/CJN.07720716
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。